These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 8024184

  • 1. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M, Goycochea MV, Meyer O, Delahousse M, Palazzo E, M'Bappé P, Kahn MF.
    Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [Abstract] [Full Text] [Related]

  • 5. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus.
    McCune WJ, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox DA.
    N Engl J Med; 1988 Jun 02; 318(22):1423-31. PubMed ID: 3259286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.
    Clin Nephrol; 1994 Aug 02; 42(2):71-8. PubMed ID: 7955581
    [Abstract] [Full Text] [Related]

  • 8. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug 02; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug 02; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec 02; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 11. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T, Igarashi T, Shimizu A, Itoh Y.
    J Nippon Med Sch; 2013 Dec 02; 80(5):396-400. PubMed ID: 24189359
    [Abstract] [Full Text] [Related]

  • 12. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
    Pattaragarn A, Sumboonnanonda A, Parichatikanond P, Supavekin S, Suntornpoch V, Vongjirad A.
    J Med Assoc Thai; 2005 Nov 02; 88 Suppl 8():S232-41. PubMed ID: 16856445
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr 02; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 02; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 15. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG, Palmieri C, Salvi A, Refe MC, Strusi AS, Danieli G.
    J Clin Apher; 2002 Aug 02; 17(2):72-7. PubMed ID: 12210709
    [Abstract] [Full Text] [Related]

  • 16. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
    Clin Nephrol; 1996 Sep 02; 46(3):170-5. PubMed ID: 8879851
    [Abstract] [Full Text] [Related]

  • 17. Intravenous cyclophosphamide for lupus nephritis in Thai children.
    Vachvanichsanong P, Dissaneewate P, Winn T.
    Scand J Rheumatol; 2004 Sep 02; 33(5):339-42. PubMed ID: 15513684
    [Abstract] [Full Text] [Related]

  • 18. Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus.
    Malaviya AN, Singh RR, Sindhwani R, Singh YN, Ahujà RK, Bhuyan UN, Khare SD, Kumar A, Malaviya R, Negi PC.
    Indian J Med Res; 1992 Apr 02; 96():101-8. PubMed ID: 1428048
    [Abstract] [Full Text] [Related]

  • 19. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, Menegatti E, La Grotta R, Modena V.
    Nephrol Dial Transplant; 2011 Dec 02; 26(12):3987-92. PubMed ID: 21385860
    [Abstract] [Full Text] [Related]

  • 20. [A case of lupus nephritis resistant to steroid pulse therapy markedly improved by bolus intravenous cyclophosphamide therapy].
    Moriuchi J, Ichikawa Y, Takaya M, Shimizu H, Kurata T, Arimori S.
    Ryumachi; 1989 Aug 02; 29(4):291-6. PubMed ID: 2617371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.